| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8732800 | Revista Brasileira de Reumatologia | 2017 | 9 Pages |
Abstract
Our result suggests that the presence of ADAbs against adalimumab and infliximab as well as a higher BMI can predict subsequent drug discontinuation in axial SpA patients.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Jiwon Hwang, HyeâMi Kim, Hyemin Jeong, Jaejoon Lee, Joong Kyong Ahn, EunâMi Koh, EunâSuk Kang, HoonâSuk Cha,